Direct oral anticoagulants in patients with hypertrophic cardiomyopathy and atrial fibrillation

Authors:

Abstract
No abstract available
Funding Information
  • Instituto de Salud Carlos III (RD012/0042/0001, RD012/0042/0002, RD012/0042/0015, RD012/0042/0044, RD12/0042/0029, RD012/0042/0066, RD12/0042/0069)
  • Ministry of Economy and Competitiveness (SAF2015-71863-REDT)
  • Bristol-Myers Squibb/Pfizer (CV185-419)
  • FEDER

This publication has 21 references indexed in Scilit: